KLRS
Kalaris Therapeutics
KLRS
KLRS
81 hedge funds and large institutions have $28.8M invested in Kalaris Therapeutics in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 35
75% less capital invested
Capital invested by funds: $115M → $28.8M (-$86.7M)
Holders
81
Holding in Top 10
–
Calls
$284K
Puts
$5K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$320K | |
| 3 | +$302K | |
| 4 |
Renaissance Technologies
New York
|
+$291K |
| 5 |
D.E. Shaw & Co
New York
|
+$172K |
Top Sellers
| 1 | -$9.9M | |
| 2 | -$9.05M | |
| 3 | -$2.71M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.79M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.72M |